Treating mice bearing pancreatic cancer xenografts with PF-03084014 (150 mg/kg), alone or combined with gemcitabine, downregulated NICD Hey-1 and Hes-1, resulted in tumor regression, and reduced cancer stem cells. Here, HEY1 is linked to neoplasm.